Resveratrol has no effect in healthy obese men, study finds

April 8, 2013
Resveratrol has no effect in healthy obese men, study finds
Resveratrol appears not to have a metabolic effect in obese men, according to a study published in the April issue of Diabetes.

(HealthDay)—Resveratrol appears not to have a metabolic effect in obese men, according to a study published in the April issue of Diabetes.

Noting that animal and in vitro studies have indicated that resveratrol has an effect on obesity, diabetes, hypertension, and hyperlipidemia, Morten M. Poulsen, M.D., from Aarhus University Hospital in Denmark, and colleagues examined the metabolic effects of high-dose resveratrol in 24 obese, but otherwise healthy, men. Participants were randomized to four weeks of resveratrol or placebo.

The researchers found that there was a non-significant decrease in in both groups. No change was noted in endogenous or in the turnover and oxidation rates of glucose. No impact was noted for resveratrol supplementation on blood pressure, resting energy expenditure, rates, ectopic or visceral fat content, or inflammatory and metabolic biomarkers.

"The lack of effect disagrees with persuasive data obtained from rodent models and raises doubt about the justification of resveratrol as a human nutritional supplement in metabolic disorders," the authors write.

The study was partially funded by the Foundation.

Explore further: First clinical trial of red wine ingredient shows metabolic shifts

More information: Abstract
Full Text (subscription or payment may be required)
Editorial

Related Stories

First clinical trial of red wine ingredient shows metabolic shifts

November 1, 2011
When obese men take a relatively small dose of resveratrol in purified form every day for a month, their metabolisms change for the better. In fact, the effects appear to be as good for us as severe calorie restriction. Resveratrol ...

Resveratrol falls short in health benefits

October 25, 2012
Resveratrol, an ingredient in red wine thought to improve insulin sensitivity, reduce risk of heart disease and increase longevity, does not appear to offer these benefits in healthy women, new research at Washington University ...

Supplements of red wine antioxidant don't help obese men

November 28, 2012
(HealthDay)—Despite showing early promise in some animal studies, supplements of resveratrol, an antioxidant found aplenty in red wine, did not improve insulin sensitivity or heart health in obese men, a small trial found.

Does moderate wine consumption improve lung function?

March 8, 2012
A research team from the Netherlands assessed the impact of wine and resveratrol (a natural polyphenol found in high quantities in red wine) on lung function. It also looked at genetic factors and mechanisms by which resveratrol ...

Recommended for you

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.